Drugs / DTaP-HBV-IPV vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT00404651 Comparator | Nov 2006 → Apr 2008 | diphtheria, hepatitis B virus infection, pertussis, poliomyelitis +1 | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DTaP-HBV-IPV vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00404651 ↗ |
| Modality | Vaccine | “Biological: DTaP-HBV-IPV vaccine” NCT00404651 ↗ |
| Route | Intramuscular | “0.5 mL, IM” NCT00404651 ↗ |